Abstract
COPD is characterized by progressive, non-reversible airflow limitation, associated with an enhanced chronic inflammatory pulmonary response. It is comprised by a mixture of small airways disease (obstructive bronchiolitis) and parenchymal destruction (emphysema). In addition, large airways inflammation (chronic bronchitis) is also part of the spectrum of COPD. The relative contributions of these components vary substantially, and may affect clinical presentation, frequency of exacerbations, prognosis, and therapeutic response. COPD is strongly related to smoking. It has emerged as the third leading cause of death in the United States, the only one that has been steadily rising in the past decades. The diagnosis of COPD is based on clinical grounds and spirometric [pulmonary function testing (PFT)] evidence of non-reversible obstruction. Classification of severity relies on spirometric parameters, and worsening obstruction correlates with increasing morbidity and mortality (1,2). According to the GOLD practice guideline, imaging does not play a substantial role in the diagnosis of COPD (1,2).
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
